Cite

HARVARD Citation

    Edelman, M. et al. (n.d.). 363 An ongoing Phase 1 dose-escalation study of the folic acid-tubulysin small-molecule drug conjugate (SMDC) folate-tubulysin EC1456. European journal of cancer. pp. S75-. [Online]. 
  
Back to record